Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study

This phase III clinical trial aimed to assess the safety and demonstrate the immunogenicity of a candidate freeze-dried purified Vero cell-based rabies vaccine (PVRV-WIBP) developed for human use. A cohort of 40 participants in stage 1 and 1956 subjects in stage 2 with an age range of 10–50 years we...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaoyuan, Liang, Jing, Huang, Lili, Nian, Xuanxuan, Chen, Wei, Zhang, Jiayou, Xu, Xiao, Lin, Xuan, Wang, Yue, Shi, Jinrong, Jia, Lanxin, Li, Qingliang, Wang, Qianxi, Duan, Kai, Li, Xinguo, Ji, Yaqi, Peng, Feixia, Zhang, Wei, Xie, Zhiqiang, Wang, Yanxia, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Novel Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294720/
https://www.ncbi.nlm.nih.gov/pubmed/37249318
http://dx.doi.org/10.1080/21645515.2023.2211896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294720/
https://www.ncbi.nlm.nih.gov/pubmed/37249318
http://dx.doi.org/10.1080/21645515.2023.2211896

Ejemplares similares